Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bond with Kuliang: 2026 China-U.S. Youth Baseball Exhibition Games and Sports Festival kicks off in Fuzhou
-
Syncron Expands Integration Capabilities to Connect Aftermarket Intelligence with Enterprise Data Platforms
-
Himax Strengthens 3D Sensing Portfolio with Launch of New iToF Depth Decoder ICs for Robotics and Intelligent Vision Applications
-
Total Voting Rights and Transaction in Own Shares
-
Huhtamaki appoints Thomas Morin as President, Fiber Packaging, and member of the Global Executive Team
-
NBPE Announces Transaction in Own Shares
-
Transaction in Own Shares
-
Holding(s) in Company
-
Progress on share buyback programme
-
Notice of AGM
-
Equinor ASA: Share buy-back – second tranche for 2026
-
Elis: Disclosure of trading in own shares occured from June 22 to June 26, 2026
-
CGTN: From the people, for the people: What the July 1 Medal honors
-
JCDecaux renews Heathrow advertising contract for 8 years
-
Vect-Horus announces collaboration and license option agreement with Servier to develop targeted oligonucleotide therapeutics for rare CNS diseases
-
BUREAU VERITAS - In line with the LEAP | 28 portfolio rotation strategy, Bureau Veritas signs an agreement to sell its Oil & Petrochemicals and Coal Testing and Inspection business
-
Toobit App Adds TradingView Charting Suite
-
GXO and Co-op Extend Transport Partnership with New Five year Agreement
-
Start of Day Message
-
Press Release: Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study
-
WISeKey Shareholders Approved All Agenda Items of the 2026 Annual General Meeting
-
The National Proton Therapy Center of Portugal will be equipped with two IBA Proteus®ONE solutions
-
VALLOUREC AWARDED MAJOR CONTRACT BY AZULE ENERGY FOR THE GREATER PAJ OFFSHORE DEVELOPMENT IN ANGOLA
-
Addex Shareholders Approve All Resolutions at Annual General Meeting
-
FDA grants Priority Review to Roche’s Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
-
Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market
-
Weekly progress on share repurchase program to cover share plans and reduce capital
-
Mowi enters into a Share Purchase Agreement to divest its 9k GWT salmon farming operations in Canada East
-
Digital Realty Prices Secondary Offering of Common Stock by Blackstone
-
Questerre Preferred Shares commence trading on Euronext Growth
-
Sigenergy Breaks Ground on Phase II Intelligent Energy Center and Joint Venture Production Facility in Nantong
-
AIPOCH Launches MedSkillAudit, an AI Audit Framework to Evaluate Medical AI Agent Skills Before Deployment
-
Cal-Maine Foods Reaches Resolution with U.S. Department of Justice and 17 States’ Attorneys General
-
Ero Copper Announces Voting Results of Annual General and Special Meeting of Shareholders
-
Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock
-
Solulu Tech Expands Stablecoin Infrastructure to Support Cross-Border Payments and Multi-Currency Settlement
-
Vishay Intertechnology Announces Pricing of Public Offering of Common Stock
-
Questerre amends report on voting results from AGM and Special Meeting
-
Terrell's Windows and Siding Celebrates crossing over 50 online 5-star Reviews, Reinforcing its Role as Best Window Installers in Oklahoma City
-
Terrell's Windows and Siding Celebrates crossing over 50 online 5-star Reviews, Reinforcing its Role as Best Window Installers in Oklahoma City
-
Autheo Introduces the Internet Operating System: A Decentralized Coordination Layer for the Web, Blockchain, and AI
-
Mama’s Creations Announces Pricing of $100 Million Public Offering of Common Stock
-
Raytech Holding Limited Announces Closing of Approximately $6.2 Million Registered Direct Offering of its Ordinary Shares
-
Island Passage Accelerates toward Drilling at the EL02 Project Bougainville Island, Papua New Guinea
-
CORRECTION -- MADD Canada Commends Saskatchewan Government for Committing to Strengthening Impaired Driving Laws
-
FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2
-
Plum Acquisition Corp. IV Announces Postponement of Extraordinary General Meeting of Shareholders
-
FEMSA Schedules Conference Call to Discuss Second Quarter Financial Results
-
Abrielle Toronto Honoured with Wine Spectator’s 2026 Award of Excellence for Thoughtfully Curated, Female-Led Wine Program
-
OceanFirst Financial Corp. Completes Previously Announced Sale of $1.3 Billion of New York City Multifamily Loans
